Funding Opportunities
Internal and external funding opportunities collected by the CTSI.
CTSI PilotsThe Translational Pilot Program will solicit, review and award pilot grants designed to produce and test novel tools and methods to bridge translational gaps. |
Ignition FundsProviding ignition funding to accelerate progress for clinical and translational research projects. |
K12 FundingProviding 2-3 years of support for early-career research faculty from Wake Forest. |
Community Partnered Research AwardCommunity Engagement provides funding to support community and academic researchers via the Community Partnered Research Award. |
Special Populations Voucher FundsStudies that identify a financial need can request funds from the voucher program to help overcome barriers related to transportation, child care, etc. |
Team Grant AcceleratorSupporting planning, pre-award, and post-award stages to incentivize investigators to pursue new large awards. |
Internal
Recurring Funding Opportunities:
- CTSI - Translational Pilot Program Ignition Funds - Deadline: 02/04/25
- CTSI - Research Salary Bridge Funding - Deadline: 04/01/25
- CTSI - Early Career Salary Support - Deadline: 04/01/25
School of Medicine and Advocate Health 2024 Requests For Proposals
The WFU Program for Leadership and Character invites proposals from any WFU School of Medicine or AHWFB or Advocate Health System employee with ideas for character development programs for current and/or future clinicians (i.e. students) and/or care team members.
Character in Medicine Grant
The Character in Medicine Grant exists to empower employees of the Wake Forest University and Advocate Health System to design, implement, and/or more rigorously assess educational programs that promote participants’ character development. This grant will fund proposals to launch pilot projects, revise existing programs, and/or implement research and/or assessment on programs to better understand their character growth impacts. Funding amount will vary from $1,000 to $30,000. Projects costing above $7,500 require a preliminary discussion with Elizabeth Whiting and/or Lauren Iley-Spear.
Applications will be accepted on a rolling basis between May 2024 – August 2025. Faculty or staff from The Wake Forest University School of Medicine and Advocate Health System are encouraged to apply. Estimated time required to complete application: 30+ minutes. Download Character in Medicine Grant Application.
Contact Elizabeth Whiting or Lauren Iley-Spear with questions.
Research Centers
An Institutionally-Supported Research Center is an interdepartmental unit focused predominantly on translational, clinical and/or basic science research which facilitates development of a common, focused research agenda aligned with strategic priorities, coordinating contributions from multiple disciplines (other centers, divisions/departments, and programs). We are pleased to announce the following opportunities are now available:
- Research Centers – The purpose of this RFA is to invite applications to develop an Institutionally-Supported Advocate Health/Wake Forest University School of Medicine Research Center. This document also provides the framework for a renewal application of an existing center. Research Centers support mature areas of research that reflect depth in translational, clinical and/or basic science research. View the full RFA for Research Centers here.
- Emerging Research Centers - The purpose of this RFA is to invite applications to develop an Institutionally-Supported Advocate Health/Wake Forest University School of Medicine Emerging Research Center. This document also provides the framework for a renewal application of an existing center. Emerging Research Centers support new ideas in need of investment for growth. The investment is intended to catalyze the formation of a team for the specific purpose of developing a strategic vision in order to grow a critical base of extramurally funded research. This research can be established in translational, clinical and/or basic science research. View the full RFA for Emerging Research Centers here.
Direct questions and applications to Lynne Wagenknecht, Vice Dean for Population Health Research, and/or Lindsay Trost, CTSI Administrative Director.
Foundation
Interested applicants may contact the Foundations Relations team at foundations@wakehealth.edu.
| Pediatrics, Psychiatry, Psychology | Blue Cross BlueShield of North Carolina | Supporting Youth Mental Health and Resilience Initial Application |
$150,000 | 2/4/2025 |
| Anesthesiology | Foundation for Anesthesia Education and Research | Mentored Research Training Grants LOI |
$250,000 | 2/15/2025 |
| Cancer | Lung Cancer Research Foundation | 2025 LCRF | Bayer Research Award on Innovative Therapeutic Strategies to Treat Lung Cancers Harboring HER2 Mutations and/or Other HER2 Alterations LOI |
$500,000 | 3/3/2025 |
Burroughs Wellcome Fund's Innovation in Regulatory Science
The Innovation in Regulatory Science Award provides up to $500,000 over five years to academic investigators developing new methodologies or innovative approaches in regulatory science that will ultimately inform the regulatory decisions the Food and Drug Administration (FDA) and others make. We especially encourage applications from those seeking to advance regulatory science approaches that will expedite the realization of equitable clinical outcomes. For additional information, including eligibility requirements, please refer to the RFA.
Those interested in applying may reach out to the Foundation Relations Team for assistance throughout the proposal process. Feel free to reach out to the foundation with any questions on behalf of faculty as well.
Deadline: February 7, 2025 by 3:00PM ET
NIH
- RFA-AG-24-039: Development and Validation of Harmonized Methodologies to Measure NAD+ and Related Metabolites in Clinical Trials (U01 Clinical Trial Required)
- PAR-23-240: Alcohol and Other Substance Use Research Education Programs for Health Professionals (R25 Clinical Trial Not Allowed)
Professional Associations and Societies
Please refer to the individual Program or Funding Opportunity Announcement for deadline information.
- American Cancer Society
- The Triological Society
- American Heart Association
- American Gastroenterological Association
- American Federation for Aging Research
- Alzheimer's Association
- ALS Association
- American Diabetes Association
- Juvenile Diabetes Research Foundation
- Thoracic Surgery Foundation for Research and Education
- Society for Pediatric Dermatology
Other Opportunities
ARPA-H Launches Groundbreaking Funding Opportunity to Improve Clinical Trials
ACTR Initiative
The Advancing Clinical Trial Readiness (ACTR) announces a new funding opportunity aimed at transforming clinical trials. Clinical trials are critical for medical breakthroughs but are often slow, costly, and inaccessible to many. ARPA-H is taking bold steps to change that.
The initiative aims to create a nationwide, decentralized infrastructure enabling 90% of eligible Americans to participate in clinical trials within 30 minutes of their home. To do so, ACTR is seeking proposals to develop tools across three technical areas:
- Automatic Clinical Trial Data Prompting & Extraction
- Research and Participant Identification & Engagement
- Trial-Grade Data Validation and Auditing
For more information, including details on the upcoming Proposer's Day on January 16, 2025, please visit the website.
ARPA-H Launches Two Opportunities Focused on Accelerating the Time it Takes to Diagnose Rare Diseases and Extending the Healthspan of Americans
RAPID Diagnostics for Rare Diseases
The RAPID (Rare disease AI/ML for Precision Integrated Diagnostics) program intends to transform the rare disease diagnostic odyssey by shortening the time it takes for individuals to gain an accurate diagnosis. It is estimated that up to half of all people with a rare disease remain undiagnosed or misdiagnosed. RAPID is designed to accelerate the diagnosis of rare and ultra-rare diseases by developing highly accurate AI-based detection models for both clinical diagnostic support and direct-to-patient systems.
For more information, including details on the upcoming Proposer’s Day on January 23, 2025, please visit the website.
PROSPR for Healthy Aging
PROSPR, the PROactive Solutions for Prolonging resilience, will focus on the physiological and biochemical markers of early health changes during aging to better understand and target the underlying causes of age-related disease, with a goal to develop therapeutics aimed at prolonging healthspan for all Americans. From app to drug developers. PROSPR encourages proposals from decentralized clinical trialists, large-data harmonization experts, wearable tech and app developers, physiological and biochemical biomarker researchers, drug developers as well as from the private sector, nonprofits, and other stakeholders.
For more information, including details on the upcoming Proposer’s Day on January 24, 2025, please visit the website.
All of Us Research Program
All of Us Research Program Seeks Engagement and Enrollment Partners: The National Institutes of Health's All of Us Research Program has issues a new funding opportunity soliciting proposals to support outreach, community engagement and participant enrollment and retention efforts. The opportunity spans four specific areas of interest, including community, participant and health care provider engagement, enrollment and retention; researcher engagement; Tribal engagement; and integration of participants and advocates in program oversight.
• Proposals will be accepted on an ongoing basis through May 23, 2025
• Read the Full Announcement
NeuroNEXT Grant
The NeuroNEXT Network is designed to efficiently conduct Phase II Clinical Trials. NeuroNEXT Network is now accepting proposals. Applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) that may contribute to the justification for and provide the data required for designing a future trial, for biomarker validation studies, or for proof of mechanism clinical studies are encouraged. Successful applicants will be given access to the NeuroNEXT infrastructure to support the efficient implementation of the proposed study at multiple sites and statistical and data management.
If you are interested, please schedule a meeting to discuss your proposal with the NeuroNEXT Study Team. This opportunity is ongoing until 2028.
- Benefits of Partnering with NeuroNEXT
- Applying for a NeuroNEXT Grant
- Contact: Mysha Sissine, Program Manager
Additional Resources
Listed below are some quick ways to find external funding opportunities through search mechanisms and announcement listservs.
Additional Resources
- For detailed information on funding opportunities, search www.grants.gov with keywords related to your research interests.
- National Institutes of Health (NIH)
- NIH Career Development Awards (K-Series)
- Patient-Centered Outcomes Research Institute (PCORI)
- Health Resources and Services Administration (HRSA)
- National Science Foundation (NSF)
- North Carolina Biotechnology Center